Skip to content

Cannabis research published in 2021

Page 5 of 6: studies 81 to 100 of 112, newest first. Back to the cannabis overview

Studies

Cannabis-induced oceanic boundlessness

Journal of Psychopharmacology March 28, 2021 Mitch Earleywine, Luna F. Ueno, Maha N. Mian et al. 36 citations

Background: Despite tetrahydrocannabinol (THC)’s reputation for creating dramatic effects at high doses, empirical work rarely addresses cannabis’s impact on subjective responses common to the tryptamine psychedelics. We focused on these effects because they have preceded and covaried with the therapeutic impact of psilocybin in previous work. Aims: The current study examined if self-reported...

The Impact of Cannabis Abuse on Psychotic Symptoms and Their Severity among Cannabis Associated Psychosis Subjects: An Indian Experience

Psychocentrum Review March 25, 2021 Ramchandra Lamba, Sona Budaniya, Rajendera Kumar Acharya et al.

Use of cannabis for recreational, religious and cultures has been prevalent since ancient times. It is one of the commonest used illicit substance. While not all cannabis users develop psychiatric problems, heavy cannabis use may increase the risk of cognitive abnormalities, psychotic illness and mood disorders. This research aimed to evaluate severity of various psychotic symptoms in relation...

DOI: 10.26539/pcr.31577 (opens in new tab) Psychosis Mood Cannabis dependence Schizophrenia object-oriented programming +4

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users

Biology March 24, 2021 Nunzia La Maida, Esther Papaseit, Lucía Martínez de Soto et al. 14 citations

Synthetic cannabinoids (SCs) are one of the most frequent classes of new psychoactive substances monitored by the EU Early Warning System and World Health Organization. UR-144 is a SC with a relative low affinity for the CB1 receptor with respect to that for the CB2 receptor. As with other cannabinoid receptor agonists, it has been monitored by the EU Early Warning System since 2012 for severe...

DOI: 10.3390/biology10040257 (opens in new tab) Cannabis Heart rate Cannabinoid receptor Blood pressure +4

The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial

PLoS One March 17, 2021 Marcel O Bonn-Miller, Sue Sisley, Paula Riggs et al. 129 citations

IMPORTANCE: There is a pressing need for development of novel pharmacology for the treatment of Posttraumatic Stress Disorder (PTSD). Given increasing use of medical cannabis among US military veterans to self-treat PTSD, there is strong public interest in whether cannabis may be a safe and effective treatment for PTSD. OBJECTIVE: The aim of the present study was to collect preliminary data on...

DOI: 10.1371/journal.pone.0246990 (opens in new tab) Cannabis Placebo Randomized controlled trial Pathology +1

Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association—The Example of Cannabis and Psychosis

Schizophrenia Bulletin March 8, 2021 Jim van Os, L. Pries, M. Ten Have et al.

Abstract Hypotheses about the link between cannabis use and psychosis apply to the within-person level but have been tested mostly at the between-person level. We used a within-person design, in which a person serves as his own control, thus removing the need to consider confounding by any fixed (genetic and nongenetic) characteristic to study the prospective association between cannabis use...

Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.

Journal of basic and clinical physiology and pharmacology March 4, 2021 Marika L Forsythe, Andrew J Boileau

Post-traumatic Stress Disorder (PTSD) is a diagnosis of extreme anxiety caused by a traumatic event. Less than 10% of individuals who have experienced severe trauma will develop this disorder. Treatment options include various psychotherapies, but not all patients respond to them. Different pharmacological approaches have been explored as potential adjuvants, including using cannabinoids to...

Cannabis Use in Older Adults: A Perspective

Harvard Review of Psychiatry March 3, 2021 Haley V. Solomon, Aaron P. Greenstein, L. DeLisi

Abstract The prevalence of cannabis use among older adults (aged 65 and above) for both recreational and medicinal purposes has significantly increased in recent years. Information regarding the safety of cannabis in this population is important since aging is associated with metabolic changes, multiple morbidities, increases in prescription medication use, and an overall decline in...

Association between age of cannabis initiation and gray matter covariance networks in recent onset psychosis

Neuropsychopharmacology March 3, 2021 Nora Penzel, Linda A. Antonucci, Linda T. Betz et al. 18 citations

Cannabis use during adolescence is associated with an increased risk of developing psychosis. According to a current hypothesis, this results from detrimental effects of early cannabis use on brain maturation during this vulnerable period. However, studies investigating the interaction between early cannabis use and brain structural alterations hitherto reported inconclusive findings. We...

DOI: 10.1038/s41386-021-00977-9 (opens in new tab) Full text (opens in new tab) Psychosis Schizophrenia object-oriented programming Confounding Age of onset +4

Drogen-Trip ins Krankenhaus – starke Zunahme von Cannabis-Psychosen

Journal Club AINS March 1, 2021

Seit 2011 hat sich am Universitätsklinikum Ulm die Zahl der Psychiatriepatienten mit Cannabis-Psychose vervielfacht. Zu diesem Ergebnis kommt eine Studie der Klinik für Psychiatrie und Psychotherapie III. Veröffentlicht wurden die Ergebnisse im Journal of Clinical Psychopharmacology [1]. Publication History Publication Date: 11 March 2021 (online) © 2021. Thieme. All rights reserved. Georg...

Head in the clouds? Cannabis users' creativity in new venture ideation depends on their entrepreneurial passion and experience

March 1, 2021 Benjamin J. Warnick, Alexander S. Kier, Emily M LaFrance et al.

Abstract New venture ideation is critical to the entrepreneurial process. To generate creative ideas, some entrepreneurs turn to cannabis, proposing its benefits. However, extant research has not validated such claims. Using a new venture ideation task, we explore differences between cannabis users' and non-users' creativity in new venture ideation by assessing the originality and feasibility...

Family Members of Young Adults with Psychosis: Intentions to Use Motivational Interviewing to Address Cannabis Use

American Journal of Psychiatric Rehabilitation March 1, 2021 Ryan Petros, Denise D. Walker, A. Davis et al. 1 citation

ABSTRACT: Individuals with first episode psychosis (FEP) use cannabis at high rates. A family-based intervention grounded in motivational interviewing (MI) appears promising. Focus groups ( N = 3) were conducted with family members ( n = 8) of individuals with FEP. Questions were developed based on theory of planned behavior (TPB) to identify factors contributing to intentions to utilize MI to...

Cannabis use in Adolescence and Risk of Psychosis: Are there Factors that Moderate this Relationship? A Systematic Review and Meta-Analysis

Substance Abuse February 22, 2021 S. Kiburi, K. Molebatsi, Vuyokazi Ntlantsana et al.

Background Previous research has reported increased risk for psychosis among individuals who use cannabis during adolescence. We conducted a systematic review and meta-analysis to investigate the interaction between adolescent cannabis use and other factors in moderating risk for psychosis later in life. Method We searched four electronic databases in June 2020 for articles that assessed...

The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review

Frontiers in Psychiatry February 16, 2021 Maryam Sorkhou, Rachel H. Bedder, T. George

Background: Cannabis is known to have a broad range of effects on behavior, including experiencing a “high” and tranquility/relaxation. However, there are several adverse behavioral sequalae that can arise from cannabis use, depending on frequency of use, potency (e.g., THC content), age of onset, and cumulative exposure. This systematic review examined evidence for cannabis-related adverse...

Effect of Δ9-Tetrahydrocannabinol on Frontostriatal Resting State Functional Connectivity and Subjective Euphoric Response in Healthy Young Adults

Drug and Alcohol Dependence February 3, 2021 Natania A. Crane, K. Phan

Background: Few studies have examined how Δ9-Tetrahydrocannabinol (THC), the main psychoactive component of cannabis, impacts brain reward circuitry in humans. In this study, we examined if an acute dose of THC altered resting state functional connectivity between the striatum and prefrontal cortex among healthy young adults with limited cannabis use. Methods: Participants received THC (n=24)...

Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.

Pharmacological Research February 2021 Martina di Bartolomeo, Tibor Stark, Oriana Maria Maurel et al.

Perinatal exposure to Δ9-tetrahydrocannabinol (THC) affects brain development and might increase the incidence of psychopathology later in life, which seems to be related to a dysregulation of endocannabinoid and/or dopaminergic systems. We here evaluated the transcriptional regulation of the genes encoding for the cannabinoid CB1 receptor (Cnr1) and the dopamine D2 receptor (Drd2) in perinatal...

CANNABIS USE: PREVALENCE AND CORRELATES AMONG THE INPATIENTS OF FIRST EPISODE PSYCHOSIS AT COMBINED MILITARY HOSPITAL, LAHORE

Pakistan Armed Forces Medical Journal January 28, 2021 Mohsin Aliemuddin, Muhammad Kamran, CH Zarrar Akbar et al.

Objective: To determine the frequency and correlates of cannabis use among the psychiatric inpatients presenting with first episode of psychosis at Combined Military Hospital (CMH), Lahore. Study Design: Correlational study. Place and Duration of Study: Combined Military Hospital Lahore, from Nov 2016 to Apr 2017. Methodology: A total of 88 patients between 18-40 years of age, both male and...

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis

Psychopharmacology January 26, 2021 Eef L. Theunissen, Johannes T. Reckweg, Nadia R. P. W. Hutten et al. 20 citations

BACKGROUND: Synthetic cannabinoids (SCs) are the largest class of novel psychoactive substances (NPS) and are associated with an increased risk of overdosing and adverse events such as psychosis. JWH-018 is one of the earliest SCs and still widely available in large parts of the world. Controlled studies to assess the safety and behavioural profiles of SCs are extremely scarce. AIM: The current...

Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.

Neuroscience and biobehavioral reviews January 23, 2021 D. McCartney, Thomas R. Arkell, Christopher Irwin et al.

The increasing legal availability of cannabis has important implications for road safety. This systematic review characterised the acute effects of Δ9-THC on driving performance and driving-related cognitive skills, with a particular focus on the duration of Δ9-THC-induced impairment. Eighty publications and 1534 outcomes were reviewed. Several measures of driving performance and...

Acute Effects of Cannabis on Symptoms of Obsessive-Compulsive Disorder.

Journal of Affective Disorders January 15, 2021 Dakota Mauzay, Emily M LaFrance, Carrie Cuttler

Little is known about the the acute effects of cannabis on symptoms of OCD in humans. Therefore, this study sought to: 1) examine whether symptoms of OCD are significantly reduced after inhaling cannabis, 2) examine predictors (gender, dose, cannabis constituents, time) of these symptom changes and 3) explore potential long-term consequences of repeatedly using cannabis to self-medicate for OCD...

Peak-experience and the entheogenic use of cannabis in world religions

Journal of Psychedelic Studies January 15, 2021 Mark S. Ferrara 24 citations

AbstractThis paper demonstrates that cannabis can evoke “peak-experiences”—the name psychologist Abraham Maslow gave to fleeting moments of expanded perception indicative of self-transcendence—when used alongside more traditional religious practices such as meditation, fasting, contemplative prayer, and sacramental ritual. For that reason, religious seekers around the globe have deployed...